Artificial liver support devices as treatment option for liver failure.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Best practice & research. Clinical gastroenterology

• Publication date

  2012-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.bpg.2012.01.002PMID 22482522
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions

  2011cited by this paper
• Bench-to-beside review: Acute-on-chronic liver failure - linking the gut, liver and systemic circulation

  2011cited by this paper
• Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study

  2010cited by this paper
• 6 EXTRACORPOREAL LIVER SUPPORT BY FRACTIONATED PLASMA SEPARATION AND ADSORPTION (PROMETHEUS) IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (HELIOS STUDY): A PROSPECTIVE RANDOMIZED CONTROLLED MULTICENTER STUDY

  2010cited by this paper
• 220 PREDICTIVE FACTORS OF TRANSPLANT FREE SURVIVAL IN PATIENTS WITH FULMINANT AND SUBFULMINANT HEPATIC FAILURE: RESULTS FROM A RANDOMIZED CONTROLLED MULTICENTER TRIAL

  2009cited by this paper
• Rescue of a marginal liver graft by sequential treatment with molecular adsorbent recirculating system and transjugular intrahepatic portosystemic shunt: a case report.

  2009cited by this paper
• Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.

  2009cited by this paper
• Hemodynamic Effects of Albumin Dialysis in Patients With Liver Failure: For Better or For Worse?

  2009cited by this paper
• Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins.

  2008cited by this paper
• Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications

  2007cited by this paper
• MELD score to predict outcome in adult patients with non‐acetaminophen‐induced acute liver failure

  2007cited by this paper
• Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis

  2007cited by this paper
• Albumin-binding function is reduced in patients with decompensated cirrhosis and correlates inversely with severity of liver disease assessed by model for end-stage liver disease

  2007cited by this paper
• Modifications of intracranial pressure after molecular adsorbent recirculating system treatment in patients with acute liver failure: case reports.

  2007cited by this paper
• MARS®: a futile tool in centres without active liver transplant support

  2007cited by this paper
• Major Coagulation Disturbances During Fractionated Plasma Separation and Adsorption

  2007cited by this paper
• Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure

  2006cited by this paper
• Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.

  2006cited by this paper
• Review article: non‐biological liver support in liver failure

  2006cited by this paper
• Liver regeneration in acute severe liver impairment: a clinicopathological correlation study

  2006cited by this paper
• Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon α-2b therapy

  2005cited by this paper
• Which Are the Right Cells to be Used in a Bioartificial Liver?

  2005cited by this paper
• Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis.

  2005cited by this paper
• Outcome from molecular adsorbent recycling system (MARS™) liver dialysis following drug‐induced liver failure

  2005cited by this paper
• Albumin: Biochemical properties and therapeutic potential

  2005cited by this paper
• Artificial and bioartificial support systems for liver failure.

  2004cited by this paper
• Model for end-stage liver disease (MELD) and allocation of donor livers.

  2003cited by this paper
• Detoxifying Capacity and Kinetics of the Molecular Adsorbent Recycling System

  2003cited by this paper
• Hepatitis E virus superinfection in patients with chronic liver disease

  2002cited by this paper
• Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis

  2002cited by this paper
• The pathophysiological basis of acute-on-chronic liver failure.

  2002cited by this paper
• Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study

  2002cited by this paper
• Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane.

  2000cited by this paper
• Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial

  2000cited by this paper
• Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances.

  1999cited by this paper
• Early indicators of prognosis in fulminant hepatic failure.

  1989cited by this paper
• Multivariate analysis of prognostic factors in fulminant hepatitis B

  1986cited by this paper

• Bilirubin Removal with Therapeutic Plasma Exchange or Molecular Adsorbent Recirculating System as Treatment for Cholemic Nephropathy in Patients with Cirrhosis and Acute-on-Chronic Liver Failure: A Case Series

  2025cites this paper
• Effect of plasma adsorption and low-volume plasma exchange on intracranial pressure in acute-on-chronic liver failure: a prospective observational study

  2025cites this paper
• Advances in liver engineering with cell, scaffold, and vascularization

  2024cites this paper
• Role of N-acetylcysteine in liver injury due to dengue fever

  2023cites this paper
• Bio-Artificial Liver Support System: A Prospective Future Therapy

  2023cites this paper
• Mesenchymal Stem Cell Transplantation in Liver Diseases.

  2022cites this paper
• Current evidence on posthepatectomy liver failure: comprehensive review

  2022cites this paper
• The development of artificial livers

  2021cites this paper
• Membrane Processes in Artificial Organs

  2021cites this paper
• An overview of the various medical devices for diagnosis, monitoring, and treatment of diseases

  2021cites this paper
• Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1/Stat3 signaling

  2021cites this paper
• Membrane application for liver support devices

  2020cites this paper
• Similarities, Differences, and Potential Synergies in the Mechanism of Action of Albumin Dialysis Using the MARS Albumin Dialysis Device and the CytoSorb Hemoperfusion Device in the Treatment of Liver Failure

  2020cites this paper
• Decellularized ECM-rich hydrogel-silver nanoparticles mixture as a potential treatment for acute liver failure model.

  2020cites this paper
• Bile acid kinetic modeling in end-stage liver support patients

  2020cites this paper
• Self-Anticoagulant Nanocomposite Spheres for the Removal of Bilirubin from Whole Blood: A Step towards Wearable Artificial Liver.

  2020cites this paper
• A brief analysis of mesenchymal stem cells as biological drugs for the treatment of acute-on-chronic liver failure (ACLF): safety and potency.

  2020cites this paper
• Fructus Psoraleae–Induced Severe Liver Injury and Treatment With Two Artificial Liver Support Systems: A Case Series Study

  2020cites this paper
• Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

  2019cites this paper
• Evaluation and treatment of the critically ill cirrhotic patient

  2019cites this paper
• Extracorporeal Liver Support Devices

  2019cites this paper
• Hyper-Urgent Liver Transplantation for Posttraumatic and Surgical Iatrogenic Acute Liver Failure

  2019cites this paper
• Targeting Albumin Binding Function as a Therapy Goal in Liver Failure: Development of a Novel Adsorbent for Albumin Dialysis

  2018cites this paper
• Molecular synergistic strategy to fabricate bilirubin medical adsorbent material for hyperbilirubinemia hemoperfusion

  2018cites this paper
• The molecular adsorbent recirculating system in posthepatectomy liver failure: Results from a prospective phase I study

  2018cites this paper
• Current and prospective therapies for acute liver failure.

  2018cites this paper
• Consenso para el manejo de la falla hepática aguda en pediatría

  2017cites this paper
• Review of Extracorporeal Membrane Oxygenation and Dialysis-Based Liver Support Devices for the Use of Nephrologists

  2017cites this paper
• Prometheus therapy for the treatment of acute liver failure in patients after cardiac surgery

  2017cites this paper
• Evaluation and treatment of the critically ill cirrhotic patient

  2016cites this paper
• Guidelines on the Use of Therapeutic Apheresis in Clinical Practice–Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue

  2016cites this paper
• Introduction to Special Issue: Clinical Applications of Therapeutic Apheresis: An Evidence Based Approach. 7th Edition

  2016cites this paper
• Experimental and mathematical modelling of the culture and cryopreservation of a bioartificial liver device utilizing a 3D cell scaffold construction

  2016influential citation
• [Evaluation and treatment of the critically ill cirrhotic patient].

  2016cites this paper
• Tissue engineering of the liver

  2016cites this paper
• Extracorporeal liver support for trauma-induced hepatic dysfunction

  2016cites this paper
• Albumin dialysis with mars in post-hepatectomy liver failure (PHLF): experiences from two HPB centers

  2016influential citation
• Part of plasmapheresis with plasma filtration adsorption combined with continuous hemodiafiltration in the treatment of severe acute liver failure

  2016cites this paper
• Artificial Liver Treatment, When and Which One?

  2016cites this paper
• Acute-on-chronic liver failure: terminology, mechanisms and management

  2016cites this paper
• Acute Liver Failure

  2016influential citation
• Chapter 107 – Current Clinical Status of the Extracorporeal Liver Support Devices

  2015cites this paper
• Effects of bone marrow MSCs transfected with sRAGE on the intervention of HMGB1 induced immuno-inflammatory reaction.

  2015cites this paper
• Albumin in chronic liver disease: structure, functions and therapeutic implications

  2015cites this paper
• LIVER COMPLICATIONS IN ADULT DENGUE AND CURRENT MANAGEMENT.

  2015cites this paper
• Intensive Care Management of Children with Liver Failure

  2014cites this paper
• Molecular Absorbent Recirculating System therapy (MARS®) in pediatric acute liver failure: a single center experience

  2014cites this paper
• Early identification of patients at increased risk for hepatic insufficiency, complications and mortality after major hepatectomy.

  2014cites this paper
• Molecular adsorbent recirculating system and bioartificial devices for liver failure.

  2014cites this paper
• Monitoring of intrasplenic hepatocyte transplantation for acute-on-chronic liver failure: a prospective five-year follow-up study.

  2014cites this paper
• Uncommon Liver Diseases in ICU

  2014cites this paper
• Should MARS and PROMETHEUS be Used in Patients with Liver Disease?

  2014cites this paper
• Reduction of Elevated Cytokine Levels in Acute/Acute‐on‐Chronic Liver Failure Using Super‐Large Pore Albumin Dialysis Treatment: An In Vitro Study

  2014cites this paper
• Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: A multicenter survey on safety and efficacy

  2013cites this paper
• Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue

  2013cites this paper
• Artificial and bioartificial liver support systems for acute and acute-on-chronic hepatic failure: A meta-analysis and meta-regression

  2013influential citation
• Severe hepatic necrosis of unknown causes following ABO-incompatible liver transplantation.

  2013cites this paper
• Hyperbilirubinemia after liver transplantation: the role of coupled plasma filtration adsorption.

  2013cites this paper
• The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children

  2013cites this paper
• Of pills, plants, and paraquat: the relevance of poison centers in emergency medicine.

  2013cites this paper
• Comparison of plasmapheresis and molecular adsorbent recirculating system efficacy in graft failure after living donor liver transplantation.

  2013cites this paper
• Activated carbon & carbon-cryogel composites for haemoperfusion based applications

  2013cites this paper
• Rationale for therapeutic apheresis

  2013cites this paper
• A preliminary study for constructing a bioartificial liver device with induced pluripotent stem cell-derived hepatocytes

  2012cites this paper
• Hypoalbuminemia

  2012cites this paper
• Gastroenterología y Hepatología

  year unknowncites this paper